These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aminosalicylates for active disease and in the maintenance of remission in Crohn's disease. Feagan BG Eur J Surg; 1998 Dec; 164(12):903-9. PubMed ID: 10029385 [No Abstract] [Full Text] [Related]
4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy. Nørgård BM Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578 [TBL] [Abstract][Full Text] [Related]
5. Dermatofibroma in a patient with Crohn's disease: a novel clinical manifestation. Beyazit Y; Caner S; Kurt M; Kekilli M; Aydog G; Ibis M J Crohns Colitis; 2010 Oct; 4(4):490-1. PubMed ID: 21122552 [No Abstract] [Full Text] [Related]
6. Crohn's disease of the mouth. Fedotin MS; Grimmett GM; Shelburne J Am J Dig Dis; 1974 Apr; 19(4):385-8. PubMed ID: 4150727 [No Abstract] [Full Text] [Related]
7. Crohn's disease involving the lung: resolution with infliximab. Alrashid AI; Brown RD; Mihalov ML; Sekosan M; Pastika BJ; Venu RP Dig Dis Sci; 2001 Aug; 46(8):1736-9. PubMed ID: 11508676 [No Abstract] [Full Text] [Related]
8. A comparison of budesonide and mesalamine for active Crohn's disease. Lowry PW; Sandborn WJ Gastroenterology; 1999 May; 116(5):1263. PubMed ID: 10220523 [No Abstract] [Full Text] [Related]
9. [Ulcerous colitis and Crohn's disease in members of one family: case description and review of literature]. Neĭman KP; Rumiantsev VG Eksp Klin Gastroenterol; 2006; (3):56-60. PubMed ID: 17203844 [No Abstract] [Full Text] [Related]
10. [Chronic regional enterocolitis (Crohn's disease) in juveniles]. Ehrenpreis T; Gierup J; Lagercrantz R Nord Med; 1967 Jan; 77(4):111-6. PubMed ID: 4381124 [No Abstract] [Full Text] [Related]
14. Esophageal stricture in Crohn's disease--a case report. Yanaga K; Iwamatsu M; Yukizane T; Shimizu T Jpn J Surg; 1986 Jan; 16(1):68-72. PubMed ID: 2870205 [TBL] [Abstract][Full Text] [Related]
15. Development of crohn's disease following treatment for juvenile idiopathic arthritis in a nigerian child: Case report and review of literature. Adeniyi OF; Ima-Edomwonyi U; Odeghe AE; Onyekwelu IV Ann Afr Med; 2019; 18(4):206-209. PubMed ID: 31823956 [TBL] [Abstract][Full Text] [Related]
16. [Perianal ulceration as a diagnostic pathway to Crohn's regional enteritis]. Weidner F; Hornstein OP Z Haut Geschlechtskr; 1971 Dec; 46(24):831-7. PubMed ID: 4400564 [No Abstract] [Full Text] [Related]
17. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Modigliani R; Colombel JF; Dupas JL; Dapoigny M; Costil V; Veyrac M; Duclos B; Soulé JC; Gendre JP; Galmiche JP; Danne O; Cadiot G; Lamouliatte H; Belaïche J; Mary JY Gastroenterology; 1996 Mar; 110(3):688-93. PubMed ID: 8608877 [TBL] [Abstract][Full Text] [Related]
18. Relationships between drug regime and histology of rectal mucosa in Crohn's disease. Schmitz-Moormann P; Brandes JW; Jesdinsky H; Knapp M Pathol Res Pract; 1988 Feb; 183(1):30-4. PubMed ID: 2896346 [TBL] [Abstract][Full Text] [Related]
19. Aminosalicylates for induction of remission or response in Crohn's disease. Lim WC; Hanauer S Cochrane Database Syst Rev; 2010 Dec; (12):CD008870. PubMed ID: 21154400 [TBL] [Abstract][Full Text] [Related]